Exact Mass: 870.7257

TG(15:0/18:0/20:3(5Z,8Z,11Z))

C56H102O6 (870.7676)

TG(15:0/18:0/20:3(5Z,8Z,11Z)) is a monomead acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:0/20:3(5Z,8Z,11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of mead acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:0/20:3n6)

C56H102O6 (870.7676)

TG(15:0/18:0/20:3n6) is a monohomo-g-linolenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:0/20:3n6), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of homo-g-linolenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:0/18:3(6Z,9Z,12Z))

C56H102O6 (870.7676)

TG(15:0/20:0/18:3(6Z,9Z,12Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of g-linolenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:0/18:3(9Z,12Z,15Z))

C56H102O6 (870.7676)

TG(15:0/20:0/18:3(9Z,12Z,15Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of a-linolenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/16:1(9Z)/22:2(13Z,16Z))

C56H102O6 (870.7676)

TG(15:0/16:1(9Z)/22:2(13Z,16Z)) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/16:1(9Z)/22:2(13Z,16Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:1(11Z)/20:2n6)

C56H102O6 (870.7676)

TG(15:0/18:1(11Z)/20:2n6) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:1(11Z)/20:2n6), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:1(9Z)/20:2n6)

C56H102O6 (870.7676)

TG(15:0/18:1(9Z)/20:2n6) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:1(9Z)/20:2n6), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:1(11Z)/18:2(9Z,12Z))

C56H102O6 (870.7676)

TG(15:0/20:1(11Z)/18:2(9Z,12Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:1(11Z)/18:2(9Z,12Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of linoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:3(5Z,8Z,11Z)/18:0)

C56H102O6 (870.7676)

TG(15:0/20:3(5Z,8Z,11Z)/18:0) is a monomead acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:3(5Z,8Z,11Z)/18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of mead acid at the C-2 position and one chain of stearic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:2(9Z,12Z)/20:1(11Z))

C56H102O6 (870.7676)

TG(15:0/18:2(9Z,12Z)/20:1(11Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:2(9Z,12Z)/20:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of linoleic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:3(6Z,9Z,12Z)/20:0)

C56H102O6 (870.7676)

TG(15:0/18:3(6Z,9Z,12Z)/20:0) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:3(6Z,9Z,12Z)/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of g-linolenic acid at the C-2 position and one chain of arachidic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:2n6/18:1(11Z))

C56H102O6 (870.7676)

TG(15:0/20:2n6/18:1(11Z)) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:2n6/18:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of eicosadienoic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:2n6/18:1(9Z))

C56H102O6 (870.7676)

TG(15:0/20:2n6/18:1(9Z)) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:2n6/18:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of eicosadienoic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/20:3n6/18:0)

C56H102O6 (870.7676)

TG(15:0/20:3n6/18:0) is a monohomo-g-linolenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/20:3n6/18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of homo-g-linolenic acid at the C-2 position and one chain of stearic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/22:2(13Z,16Z)/16:1(9Z))

C56H102O6 (870.7676)

TG(15:0/22:2(13Z,16Z)/16:1(9Z)) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/22:2(13Z,16Z)/16:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of docosadienoic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(15:0/18:3(9Z,12Z,15Z)/20:0)

C56H102O6 (870.7676)

TG(15:0/18:3(9Z,12Z,15Z)/20:0) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(15:0/18:3(9Z,12Z,15Z)/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position, one chain of a-linolenic acid at the C-2 position and one chain of arachidic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:0/15:0/20:3(5Z,8Z,11Z))

C56H102O6 (870.7676)

TG(18:0/15:0/20:3(5Z,8Z,11Z)) is a monomead acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/15:0/20:3(5Z,8Z,11Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of mead acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:0/15:0/20:3n6)

C56H102O6 (870.7676)

TG(18:0/15:0/20:3n6) is a monohomo-g-linolenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/15:0/20:3n6), in particular, consists of one chain of stearic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of homo-g-linolenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(20:0/15:0/18:3(6Z,9Z,12Z))

C56H102O6 (870.7676)

TG(20:0/15:0/18:3(6Z,9Z,12Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/15:0/18:3(6Z,9Z,12Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of g-linolenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(20:0/15:0/18:3(9Z,12Z,15Z))

C56H102O6 (870.7676)

TG(20:0/15:0/18:3(9Z,12Z,15Z)) is a monoarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/15:0/18:3(9Z,12Z,15Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of a-linolenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(16:1(9Z)/15:0/22:2(13Z,16Z))

C56H102O6 (870.7676)

TG(16:1(9Z)/15:0/22:2(13Z,16Z)) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:1(9Z)/15:0/22:2(13Z,16Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:1(11Z)/15:0/20:2n6)

C56H102O6 (870.7676)

TG(18:1(11Z)/15:0/20:2n6) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(11Z)/15:0/20:2n6), in particular, consists of one chain of vaccenic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(18:1(9Z)/15:0/20:2n6)

C56H102O6 (870.7676)

TG(18:1(9Z)/15:0/20:2n6) is a monoeicosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(9Z)/15:0/20:2n6), in particular, consists of one chain of oleic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

TG(20:1(11Z)/15:0/18:2(9Z,12Z))

C56H102O6 (870.7676)

TG(20:1(11Z)/15:0/18:2(9Z,12Z)) is a monoeicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:1(11Z)/15:0/18:2(9Z,12Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position, one chain of pentadecanoic acid at the C-2 position and one chain of linoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

PA(24:0/24:1(15Z))

C51H99O8P (870.7077)

PA(24:0/24:1(15Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(24:0/24:1(15Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of nervonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

PA(24:1(15Z)/24:0)

C51H99O8P (870.7077)

PA(24:1(15Z)/24:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(24:1(15Z)/24:0), in particular, consists of one chain of nervonic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Aluminum oleate

C54H99AlO6 (870.7257)

It is used as a food additive .

Halicylindroside A3

C50H98N2O9 (870.7272)

Triacylglycerol 17:1-18:1-18:1

C56H102O6 (870.7676)

TG 18:1-17:1-18:1-d5

C56H102O6 (870.7676)

citrusteryl arachidate|stigmast-5-en-3beta-ol-3beta-D-glucopyranosyl-4-eicosanoate

C55H98O7 (870.7312)

??-Sitosterol-3-O-??-D-glucoside-6-O-eicosanate

C55H98O7 (870.7312)

TG(14:0/17:0/22:3(10Z,13Z,16Z))[iso6]

C56H102O6 (870.7676)

TG(14:0/17:1(9Z)/22:2(13Z,16Z))[iso6]

C56H102O6 (870.7676)

TG(14:0/17:2(9Z,12Z)/22:1(11Z))[iso6]

C56H102O6 (870.7676)

TG(14:0/18:3(6Z,9Z,12Z)/21:0)[iso6]

C56H102O6 (870.7676)

TG(14:0/18:3(9Z,12Z,15Z)/21:0)[iso6]

C56H102O6 (870.7676)

TG(14:0/19:0/20:3(8Z,11Z,14Z))[iso6]

C56H102O6 (870.7676)

TG(14:0/19:1(9Z)/20:2(11Z,14Z))[iso6]

C56H102O6 (870.7676)

TG(14:1(9Z)/17:0/22:2(13Z,16Z))[iso6]

C56H102O6 (870.7676)

TG(14:1(9Z)/17:1(9Z)/22:1(11Z))[iso6]

C56H102O6 (870.7676)

TG(14:1(9Z)/17:2(9Z,12Z)/22:0)[iso6]

C56H102O6 (870.7676)

TG(14:1(9Z)/18:2(9Z,12Z)/21:0)[iso6]

C56H102O6 (870.7676)

TG(14:1(9Z)/19:0/20:2(11Z,14Z))[iso6]

C56H102O6 (870.7676)

TG(14:1(9Z)/19:1(9Z)/20:1(11Z))[iso6]

C56H102O6 (870.7676)

TG(15:0/16:0/22:3(10Z,13Z,16Z))[iso6]

C56H102O6 (870.7676)

TG(15:0/16:1(9Z)/22:2(13Z,16Z))[iso6]

C56H102O6 (870.7676)

TG(15:0/18:0/20:3(8Z,11Z,14Z))[iso6]

C56H102O6 (870.7676)

TG(15:0/18:1(9Z)/20:2(11Z,14Z))[iso6]

C56H102O6 (870.7676)

TG(15:0/18:2(9Z,12Z)/20:1(11Z))[iso6]

C56H102O6 (870.7676)

TG(15:0/18:3(6Z,9Z,12Z)/20:0)[iso6]

C56H102O6 (870.7676)

TG(15:0/18:3(9Z,12Z,15Z)/20:0)[iso6]

C56H102O6 (870.7676)

TG(15:1(9Z)/16:0/22:2(13Z,16Z))[iso6]

C56H102O6 (870.7676)

TG(15:1(9Z)/16:1(9Z)/22:1(11Z))[iso6]

C56H102O6 (870.7676)

TG(15:1(9Z)/17:2(9Z,12Z)/21:0)[iso6]

C56H102O6 (870.7676)

TG(15:1(9Z)/18:0/20:2(11Z,14Z))[iso6]

C56H102O6 (870.7676)

TG(15:1(9Z)/18:1(9Z)/20:1(11Z))[iso6]

C56H102O6 (870.7676)

TG(15:1(9Z)/18:2(9Z,12Z)/20:0)[iso6]

C56H102O6 (870.7676)

TG(16:0/18:2(9Z,12Z)/19:1(9Z))[iso6]

C56H102O6 (870.7676)

TG(16:0/18:3(6Z,9Z,12Z)/19:0)[iso6]

C56H102O6 (870.7676)

TG(16:1(9Z)/18:1(9Z)/19:1(9Z))[iso6]

C56H102O6 (870.7676)

TG(17:0/17:2(9Z,12Z)/19:1(9Z))[iso6]

C56H102O6 (870.7676)

TG(17:0/18:0/18:3(6Z,9Z,12Z))[iso6]

C56H102O6 (870.7676)

22:0-Glc-Cholesterol

C55H98O7 (870.7312)

20:0-Glc-Sitosterol

C55H98O7 (870.7312)

TG(17:1/18:1/18:1)[iso3]

C56H102O6 (870.7676)

TG(17:2/18:0/18:1)[iso6]

C56H102O6 (870.7676)

TG(17:0/18:1/18:2)[iso6]

C56H102O6 (870.7676)

TG(17:1/18:0/18:2)[iso6]

C56H102O6 (870.7676)

TG(17:0/18:0/18:3)[iso6]

C56H102O6 (870.7676)

TG(16:1/17:2/20:0)[iso6]

C56H102O6 (870.7676)

TG(16:0/17:2/20:1)[iso6]

C56H102O6 (870.7676)

ST 29:1;O;Hex;FA 20:0

C55H98O7 (870.7312)

aluminum oleate

C54H99AlO6 (870.7257)

2-[[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-icosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-docosanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-3-docosanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-icosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-3-[(Z)-octadec-11-enoyl]oxy-2-[(Z)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-3-[(Z)-octadec-9-enoyl]oxy-2-[(Z)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-2-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-3-[(Z)-docos-13-enoyl]oxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-2-[(Z)-octadec-11-enoyl]oxy-3-[(Z)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-[(5Z,9Z)-hexacosa-5,9-dienoyl]oxy-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

NAGlySer 26:1/22:3

C53H94N2O7 (870.7061)

NAGlySer 22:0/26:4

C53H94N2O7 (870.7061)

NAGlySer 24:2/24:2

C53H94N2O7 (870.7061)

NAGlySer 22:2/26:2

C53H94N2O7 (870.7061)

NAGlySer 22:4/26:0

C53H94N2O7 (870.7061)

NAGlySer 26:4/22:0

C53H94N2O7 (870.7061)

NAGlySer 26:3/22:1

C53H94N2O7 (870.7061)

NAGlySer 22:3/26:1

C53H94N2O7 (870.7061)

NAGlySer 26:2/22:2

C53H94N2O7 (870.7061)

NAGlySer 24:3/24:1

C53H94N2O7 (870.7061)

NAGlySer 24:4/24:0

C53H94N2O7 (870.7061)

NAGlySer 26:0/22:4

C53H94N2O7 (870.7061)

NAGlySer 24:0/24:4

C53H94N2O7 (870.7061)

ST 27:1;O;Hex;FA 22:0

C55H98O7 (870.7312)

[(8E,12E)-2-(heptacosanoylamino)-3,4-dihydroxyoctadeca-8,12-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C50H99N2O7P (870.719)

Mgdg O-18:0_25:0

C52H102O9 (870.7523)

Mgdg O-22:0_21:0

C52H102O9 (870.7523)

Mgdg O-17:0_26:0

C52H102O9 (870.7523)

Mgdg O-21:0_22:0

C52H102O9 (870.7523)

Mgdg O-27:0_16:0

C52H102O9 (870.7523)

ST 28:1;O;Hex;FA 21:0

C55H98O7 (870.7312)

Mgdg O-24:0_19:0

C52H102O9 (870.7523)

Mgdg O-15:0_28:0

C52H102O9 (870.7523)

Mgdg O-20:0_23:0

C52H102O9 (870.7523)

Mgdg O-26:0_17:0

C52H102O9 (870.7523)

Mgdg O-23:0_20:0

C52H102O9 (870.7523)

Mgdg O-16:0_27:0

C52H102O9 (870.7523)

Mgdg O-19:0_24:0

C52H102O9 (870.7523)

Mgdg O-25:0_18:0

C52H102O9 (870.7523)

Mgdg O-28:0_15:0

C52H102O9 (870.7523)

PE-Cer 25:1;2O/24:0

C51H103N2O6P (870.7553)

PE-Cer 25:0;2O/24:1

C51H103N2O6P (870.7553)

PE-Cer 24:1;2O/25:0

C51H103N2O6P (870.7553)

PE-Cer 26:1;2O/23:0

C51H103N2O6P (870.7553)

PE-Cer 23:0;2O/26:1

C51H103N2O6P (870.7553)

PE-Cer 23:1;2O/26:0

C51H103N2O6P (870.7553)

PE-Cer 26:1;2O/22:1;O

C50H99N2O7P (870.719)

PE-Cer 24:0;2O/24:2;O

C50H99N2O7P (870.719)

PE-Cer 24:2;2O/24:0;O

C50H99N2O7P (870.719)

PE-Cer 22:0;2O/26:2;O

C50H99N2O7P (870.719)

PE-Cer 24:1;2O/24:1;O

C50H99N2O7P (870.719)

PE-Cer 22:2;2O/26:0;O

C50H99N2O7P (870.719)

PE-Cer 25:1;2O/23:1;O

C50H99N2O7P (870.719)

PE-Cer 23:2;2O/25:0;O

C50H99N2O7P (870.719)

PE-Cer 23:1;2O/25:1;O

C50H99N2O7P (870.719)

PE-Cer 26:0;2O/22:2;O

C50H99N2O7P (870.719)

PE-Cer 26:2;2O/22:0;O

C50H99N2O7P (870.719)

PE-Cer 25:2;2O/23:0;O

C50H99N2O7P (870.719)

PE-Cer 22:1;2O/26:1;O

C50H99N2O7P (870.719)

[(E)-3-hydroxy-2-(octatriacontanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[1-hydroxy-3-[(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoxy]propan-2-yl] (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C59H98O4 (870.7465)

[1-hydroxy-3-[(13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoxy]propan-2-yl] (13Z,16Z,19Z,22Z,25Z)-octacosa-13,16,19,22,25-pentaenoate

C59H98O4 (870.7465)

[(E)-2-(heptatriacontanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[1-hydroxy-3-[(10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoxy]propan-2-yl] (16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoate

C59H98O4 (870.7465)

[1-hydroxy-3-[(16Z,19Z,22Z,25Z)-octacosa-16,19,22,25-tetraenoxy]propan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-10,13,16,19,22,25-hexaenoate

C59H98O4 (870.7465)

[(E)-3-hydroxy-2-(nonanoylamino)heptatriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[1-hydroxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z)-octacosa-7,10,13,16,19,22,25-heptaenoate

C59H98O4 (870.7465)

[2-[[(Z)-hexatriacont-25-enoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxyicosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]docosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(tetratriacontanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxynonacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tritriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxypentacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxytriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

SM 31:1;2O(FA 14:0)

C50H99N2O7P (870.719)

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]dotriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-octacos-17-enoyl]amino]octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(tetradecanoylamino)dotriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]octacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(undecanoylamino)pentatriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-docos-13-enoyl]amino]-3-hydroxytetracosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]hentriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(dodecanoylamino)-3-hydroxytetratriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(tridecanoylamino)tritriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-dotriacont-21-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(tritriacontanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-tetratriacont-23-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(decanoylamino)-3-hydroxyhexatriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(pentadecanoylamino)hentriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(pentatriacontanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-triacont-19-enoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(hexatriacontanoylamino)-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropan-2-yl] (12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-12,15,18,21,24,27,30,33-octaenoate

C58H94O5 (870.7101)

[1-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-10,13,16,19,22,25,28,31-octaenoate

C58H94O5 (870.7101)

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-13,16,19,22,25,28,31,34,37-nonaenoate

C58H94O5 (870.7101)

[1-[(Z)-henicos-11-enoyl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenoate

C58H94O5 (870.7101)

[1-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-14,17,20,23,26,29,32,35-octaenoate

C58H94O5 (870.7101)

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-15,18,21,24,27,30,33,36,39-nonaenoate

C58H94O5 (870.7101)

[1-[(Z)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-11,14,17,20,23,26,29,32,35-nonaenoate

C58H94O5 (870.7101)

[1-hydroxy-3-[(Z)-nonadec-9-enoyl]oxypropan-2-yl] (9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenoate

C58H94O5 (870.7101)

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-tetraconta-10,13,16,19,22,25,28,31,34,37-decaenoate

C58H94O5 (870.7101)

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z,36Z,39Z)-dotetraconta-12,15,18,21,24,27,30,33,36,39-decaenoate

C58H94O5 (870.7101)

(1-heptadecanoyloxy-3-hydroxypropan-2-yl) (8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-octatriaconta-8,11,14,17,20,23,26,29,32,35-decaenoate

C58H94O5 (870.7101)

(1-hydroxy-3-nonadecanoyloxypropan-2-yl) (6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-hexatriaconta-6,9,12,15,18,21,24,27,30,33-decaenoate

C58H94O5 (870.7101)

(1-hydroxy-3-undecanoyloxypropan-2-yl) (14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z,38Z,41Z)-tetratetraconta-14,17,20,23,26,29,32,35,38,41-decaenoate

C58H94O5 (870.7101)

PMeOH 25:0_22:1

C51H99O8P (870.7077)

PMeOH 26:0_21:1

C51H99O8P (870.7077)

PEtOH 24:0_22:1

C51H99O8P (870.7077)

PEtOH 27:0_19:1

C51H99O8P (870.7077)

PEtOH 20:0_26:1

C51H99O8P (870.7077)

PEtOH 26:0_20:1

C51H99O8P (870.7077)

PEtOH 22:0_24:1

C51H99O8P (870.7077)

PMeOH 21:0_26:1

C51H99O8P (870.7077)

PEtOH 25:0_21:1

C51H99O8P (870.7077)

PMeOH 23:0_24:1

C51H99O8P (870.7077)

PMeOH 27:0_20:1

C51H99O8P (870.7077)

[1-Hexadecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexacosanoate

C51H98O10 (870.716)

[1-Heptadecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentacosanoate

C51H98O10 (870.716)

[1-Octadecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetracosanoate

C51H98O10 (870.716)

[1-Nonadecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tricosanoate

C51H98O10 (870.716)

[1-Icosanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] docosanoate

C51H98O10 (870.716)

[2-Henicosanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] henicosanoate

C51H98O10 (870.716)

[1-Pentadecanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptacosanoate

C51H98O10 (870.716)

[3-hydroxy-2-[[(Z)-octatriacont-27-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(pentacosanoylamino)henicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(tricosanoylamino)tricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(heptadecanoylamino)-3-hydroxynonacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(docosanoylamino)-3-hydroxytetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(icosanoylamino)hexacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(triacontanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]hexacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(hexadecanoylamino)-3-hydroxytriacont-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(tetracosanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]heptacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(heptacosanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(henicosanoylamino)-3-hydroxypentacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(nonadecanoylamino)heptacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(octacosanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(hexacosanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(hentriacontanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-2-(dotriacontanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(octadecanoylamino)octacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(E)-3-hydroxy-2-(nonacosanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[(Z)-docos-13-enoyl]oxy-3-phosphonooxypropyl] hexacosanoate

C51H99O8P (870.7077)

(1-docosanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexacos-15-enoate

C51H99O8P (870.7077)

[3-phosphonooxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] tetracosanoate

C51H99O8P (870.7077)

[2-[(Z)-henicos-11-enoyl]oxy-3-phosphonooxypropyl] heptacosanoate

C51H99O8P (870.7077)

[2-[[(Z)-hentriacont-16-enoyl]amino]-3-hydroxypentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-pentacos-11-enoyl]amino]henicosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxytriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-triacont-15-enoyl]amino]hexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-nonacos-14-enoyl]amino]heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-tetracos-11-enoyl]amino]docosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-tricos-11-enoyl]amino]tricosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-docos-11-enoyl]amino]-3-hydroxytetracosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-dotriacont-17-enoyl]amino]-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-hexacos-11-enoyl]amino]-3-hydroxyicosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-heptacos-12-enoyl]amino]-3-hydroxynonadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]octacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxypentacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[3-hydroxy-2-[[(Z)-octacos-13-enoyl]amino]octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

N-(pentacosanoyl)-4E-heneicosasphingenine-1-phosphocholine

C51H103N2O6P (870.7553)

N-(tetracosanoyl)-4E-docosasphingenine-1-phosphocholine

C51H103N2O6P (870.7553)

N-(hexacosanoyl)-4E-eicosasphingenine-1-phosphocholine

C51H103N2O6P (870.7553)

[1-carboxy-3-[2-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2S,3R)-3-hydroxy-2-[[(E)-tetracos-15-enoyl]amino]docosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

2-[[(2R)-2-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-icosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[3-[(E)-henicos-9-enoyl]oxy-2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2R)-3-phosphonooxy-2-[(E)-tetracos-15-enoyl]oxypropyl] tetracosanoate

C51H99O8P (870.7077)

[1-carboxy-3-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-[(E)-tricos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-[(E)-pentacos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2S)-1-icosanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] docosanoate

C51H98O10 (870.716)

[1-carboxy-3-[2-[(E)-henicos-9-enoyl]oxy-3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-docosanoyloxy-2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-henicosanoyloxy-2-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2R)-2-nonadecanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tricosanoate

C51H98O10 (870.716)

[1-carboxy-3-[2-[(E)-nonadec-9-enoyl]oxy-3-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2S)-2-[(E)-octadec-7-enoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2S,3R)-2-[[(E)-hexacos-17-enoyl]amino]-3-hydroxyicosyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

2-[[(2R)-3-[(E)-docos-13-enoyl]oxy-2-[(E)-icos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[3-[(14E,17E,20E,23E)-hexacosa-14,17,20,23-tetraenoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2R)-3-octadec-17-enoyloxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[3-[(E)-icos-11-enoyl]oxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(E,2S,3R)-3-hydroxy-2-(tetracosanoylamino)docos-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-phosphonooxypropyl] hexacosanoate

C51H99O8P (870.7077)

2-[hydroxy-[(2R)-3-[(6E,9E)-octadeca-6,9-dienoyl]oxy-2-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-[(E)-hexacos-5-enoyl]oxy-3-[(E)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2S)-2-octadec-17-enoyloxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[(2R)-2-hexadecanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] hexacosanoate

C51H98O10 (870.716)

2-[[(2R)-2-docosanoyloxy-3-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[3-hexacosanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[(2R)-3-docosanoyloxy-2-[(5E,8E)-icosa-5,8-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-pentacosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2S)-2-[(E)-octadec-6-enoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[3-nonadecanoyloxy-2-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(9E,11E)-henicosa-9,11-dienoyl]oxy-2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-henicosanoyloxy-3-[(8E,11E,14E,17E,20E)-tricosa-8,11,14,17,20-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2R)-2-heptadecanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] pentacosanoate

C51H98O10 (870.716)

2-[hydroxy-[(2S)-2-[(9E,12E)-octadeca-9,12-dienoyl]oxy-3-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-3-[(2E,4E)-octadeca-2,4-dienoyl]oxy-2-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-3-[(E)-octadec-13-enoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-3-[(E)-octadec-4-enoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-[(E)-docos-13-enoyl]oxy-3-[(E)-icos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-3-[(9E,12E)-octadeca-9,12-dienoyl]oxy-2-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2S)-2-[(6E,9E)-octadeca-6,9-dienoyl]oxy-3-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-3-octadecanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(E,2S,3R)-2-(hexacosanoylamino)-3-hydroxyicos-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

2-[[3-hexacosanoyloxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2S)-2-[(E)-octadec-4-enoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(E)-hexacos-11-enoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2R)-3-[(E)-octadec-6-enoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[(2R)-1-phosphonooxy-3-[(E)-tetracos-15-enoyl]oxypropan-2-yl] tetracosanoate

C51H99O8P (870.7077)

2-[[(2S)-3-[(E)-hexacos-5-enoyl]oxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-[(11E,14E)-pentacosa-11,14-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-docosanoyloxy-3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[(2R)-3-docosanoyloxy-2-[(11E,14E)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-[(E)-tricos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[(2S)-3-[(E)-hexacos-5-enoyl]oxy-2-[(E)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(E)-docos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[(2R)-2-[(E)-docos-13-enoyl]oxy-3-[(E)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-pentacosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2S)-2-[(E)-octadec-11-enoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-[(E)-pentacos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-[(E)-icos-11-enoyl]oxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2R)-2-docosanoyloxy-3-phosphonooxypropyl] (E)-hexacos-5-enoate

C51H99O8P (870.7077)

[1-carboxy-3-[3-[(11E,14E)-hexacosa-11,14-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2R)-3-[(E)-octadec-11-enoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[(2S)-1-nonadecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tricosanoate

C51H98O10 (870.716)

[1-carboxy-3-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2S)-1-hexadecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexacosanoate

C51H98O10 (870.716)

2-[hydroxy-[(2S)-2-[(2E,4E)-octadeca-2,4-dienoyl]oxy-3-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[(E,2S,3R)-3-hydroxy-2-(pentacosanoylamino)henicos-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C51H103N2O6P (870.7553)

[1-carboxy-3-[2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-3-pentacosanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[(2R)-3-[(E)-docos-13-enoyl]oxy-2-[(E)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(9E,11E)-henicosa-9,11-dienoyl]oxy-3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2S)-2-[(E)-octadec-9-enoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-3-tricosanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-2-pentacosanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-2-[(E)-tetracos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2R)-3-[(E)-octadec-7-enoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[(2R)-1-[(E)-docos-13-enoyl]oxy-3-phosphonooxypropan-2-yl] hexacosanoate

C51H99O8P (870.7077)

[(2R)-2-henicosanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] henicosanoate

C51H98O10 (870.716)

[1-carboxy-3-[2-icosanoyloxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[(2R)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-icosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-[(E)-docos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2S)-2-[(9E,11E)-octadeca-9,11-dienoyl]oxy-3-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(14E,16E)-tricosa-14,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2R)-2-octadecanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tetracosanoate

C51H98O10 (870.716)

[1-carboxy-3-[3-[(E)-hexacos-11-enoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2R)-1-docosanoyloxy-3-phosphonooxypropan-2-yl] (E)-hexacos-5-enoate

C51H99O8P (870.7077)

[1-carboxy-3-[3-icosanoyloxy-2-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2R)-3-[(E)-octadec-9-enoyl]oxy-2-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-3-[(E)-tetracos-11-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(9E,11E,13E,15E,17E)-henicosa-9,11,13,15,17-pentaenoyl]oxy-2-tricosanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-octadecanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[(2S)-2-[(E)-octadec-13-enoyl]oxy-3-[(E)-tetracos-15-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-hexacosanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(13E,16E,19E)-pentacosa-13,16,19-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(17E,20E,23E)-hexacosa-17,20,23-trienoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2S)-1-heptadecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentacosanoate

C51H98O10 (870.716)

[(2S)-1-octadecanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetracosanoate

C51H98O10 (870.716)

2-[[(2S)-3-[(5E,9E)-hexacosa-5,9-dienoyl]oxy-2-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[(2R)-3-[(9E,11E)-octadeca-9,11-dienoyl]oxy-2-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-[(E)-hexacos-5-enoyl]oxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[(2R)-2-docosanoyloxy-3-[(5E,8E)-icosa-5,8-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(E)-nonadec-9-enoyl]oxy-2-[(13E,16E,19E,22E)-pentacosa-13,16,19,22-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[(2R)-2-icosanoyloxy-3-[(2S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] docosanoate

C51H98O10 (870.716)

[1-carboxy-3-[2-nonadecanoyloxy-3-[(10E,13E,16E,19E,22E)-pentacosa-10,13,16,19,22-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(Z)-hexacos-15-enoyl]oxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-pentacosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-hexadecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-icosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-docosanoyloxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-pentacosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[3-hexacosanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-[(Z)-icos-11-enoyl]oxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[3-docosanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[2,3-bis[[(Z)-henicos-11-enoyl]oxy]propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[2-heptacosanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[2-[(Z)-hexacos-15-enoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[3-octadecanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tricosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-henicosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-[(Z)-docos-13-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[3-[(Z)-octadec-9-enoyl]oxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tetracosanoyloxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[3-hexacosanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

[1-carboxy-3-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-tetracos-13-enoyl]oxypropoxy]propyl]-trimethylazanium

C54H96NO7+ (870.7186)

2-[[3-dodecanoyloxy-2-[(19Z,22Z)-triaconta-19,22-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[3-octanoyloxy-2-[(23Z,26Z)-tetratriaconta-23,26-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[carboxy-[2-hydroxy-3-[(26Z,29Z,32Z,35Z,38Z,41Z)-tetratetraconta-26,29,32,35,38,41-hexaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium

C54H96NO7+ (870.7186)

2-[hydroxy-[2-[(Z)-octacos-17-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[2-[(17Z,20Z)-octacosa-17,20-dienoyl]oxy-3-pentadecoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[3-decanoyloxy-2-[(21Z,24Z)-dotriaconta-21,24-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[hydroxy-[2-[(17Z,20Z)-octacosa-17,20-dienoyl]oxy-3-tetradecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C50H97NO8P+ (870.6951)

2-[[3-[(Z)-docos-13-enoxy]-2-[(Z)-henicos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[2-docosanoyloxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[3-heptadecoxy-2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentacosoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-hexacosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[3-[(17Z,20Z)-octacosa-17,20-dienoxy]-2-pentadecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[2-[(Z)-octacos-17-enoyl]oxy-3-[(Z)-pentadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[3-heptacosoxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexacosoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-henicosoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[2-nonadecanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-henicos-11-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-henicosanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[3-nonadecoxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetracosoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tetracos-13-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-hexacos-15-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[2-heptadecanoyloxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-tetracosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-tricosanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tricosoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[3-docosoxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[3-[(Z)-nonadec-9-enoxy]-2-[(Z)-tetracos-13-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[[3-[(Z)-heptadec-9-enoxy]-2-[(Z)-hexacos-15-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

2-[hydroxy-[3-[(Z)-octacos-17-enoxy]-2-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C51H101NO7P+ (870.7315)

AcHexChE(22:0)

C55H98O7 (870.7312)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

BisMePA(46:1)

C51H99O8P (870.7077)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 59:9;O

C59H98O4 (870.7465)

MGDG 10:0_32:0

C51H98O10 (870.716)

MGDG 11:0_31:0

C51H98O10 (870.716)

MGDG 12:0_30:0

C51H98O10 (870.716)

MGDG 13:0_29:0

C51H98O10 (870.716)

MGDG 14:0_28:0

C51H98O10 (870.716)

MGDG 15:0_27:0

C51H98O10 (870.716)

MGDG 16:0_26:0

C51H98O10 (870.716)

MGDG 17:0_25:0

C51H98O10 (870.716)

MGDG 18:0_24:0

C51H98O10 (870.716)

MGDG 19:0_23:0

C51H98O10 (870.716)

MGDG 20:0_22:0

C51H98O10 (870.716)

MGDG 21:0_21:0

C51H98O10 (870.716)

MGDG 42:0

C51H98O10 (870.716)

MGDG O-42:1;O

C51H98O10 (870.716)

MGDG O-43:0

C52H102O9 (870.7523)

PA O-14:1/35:0

C52H103O7P (870.7441)

PA O-16:1/33:0

C52H103O7P (870.7441)

PA O-18:1/31:0

C52H103O7P (870.7441)

PA O-20:1/29:0

C52H103O7P (870.7441)

PA O-22:1/27:0

C52H103O7P (870.7441)

PA O-49:1

C52H103O7P (870.7441)

PA P-14:0/35:0

C52H103O7P (870.7441)

PA P-14:0/35:0 or PA O-14:1/35:0

C52H103O7P (870.7441)

PA P-16:0/33:0

C52H103O7P (870.7441)

PA P-16:0/33:0 or PA O-16:1/33:0

C52H103O7P (870.7441)

PA P-18:0/31:0

C52H103O7P (870.7441)

PA P-18:0/31:0 or PA O-18:1/31:0

C52H103O7P (870.7441)

PA P-20:0/29:0

C52H103O7P (870.7441)

PA P-20:0/29:0 or PA O-20:1/29:0

C52H103O7P (870.7441)

PA P-22:0/27:0

C52H103O7P (870.7441)

PA P-22:0/27:0 or PA O-22:1/27:0

C52H103O7P (870.7441)

PA P-49:0

C52H103O7P (870.7441)

PA P-49:0 or PA O-49:1

C52H103O7P (870.7441)

PA 14:1_34:0

C51H99O8P (870.7077)

PA 15:1_33:0

C51H99O8P (870.7077)

PA 16:1_32:0

C51H99O8P (870.7077)

PA 17:1_31:0

C51H99O8P (870.7077)

PA 18:1_30:0

C51H99O8P (870.7077)

PA 20:1_28:0

C51H99O8P (870.7077)

PA 22:0_26:1

C51H99O8P (870.7077)

PA 22:1_26:0

C51H99O8P (870.7077)

PA 24:0_24:1

C51H99O8P (870.7077)

PA 48:1

C51H99O8P (870.7077)

PEth 46:1

C51H99O8P (870.7077)

PM 47:1

C51H99O8P (870.7077)

CerPE 14:1;O2/35:0

C51H103N2O6P (870.7553)

CerPE 15:1;O2/34:0

C51H103N2O6P (870.7553)

CerPE 16:1;O2/33:0

C51H103N2O6P (870.7553)

CerPE 17:1;O2/32:0

C51H103N2O6P (870.7553)

CerPE 18:1;O2/31:0

C51H103N2O6P (870.7553)

CerPE 19:1;O2/30:0

C51H103N2O6P (870.7553)

CerPE 20:1;O2/29:0

C51H103N2O6P (870.7553)

CerPE 21:1;O2/28:0

C51H103N2O6P (870.7553)

CerPE 22:1;O2/27:0

C51H103N2O6P (870.7553)

CerPE 22:2;O2/26:0;O

C50H99N2O7P (870.719)

CerPE 48:2;O2;O

C50H99N2O7P (870.719)

CerPE 49:1;O2

C51H103N2O6P (870.7553)

SM 14:1;O2/32:0

C51H103N2O6P (870.7553)

SM 15:1;O2/31:0

C51H103N2O6P (870.7553)

SM 16:1;O2/30:0

C51H103N2O6P (870.7553)

SM 17:1;O2/29:0

C51H103N2O6P (870.7553)

SM 18:1;O2/28:0

C51H103N2O6P (870.7553)

SM 19:1;O2/27:0

C51H103N2O6P (870.7553)

SM 19:2;O2/26:0;O

C50H99N2O7P (870.719)

SM 20:0;O2/26:1

C51H103N2O6P (870.7553)

SM 20:1;O2/26:0

C51H103N2O6P (870.7553)

SM 20:2;O2/25:0;O

C50H99N2O7P (870.719)

SM 21:1;O2/24:1;O

C50H99N2O7P (870.719)

SM 21:1;O2/25:0

C51H103N2O6P (870.7553)

SM 21:2;O2/24:0;O

C50H99N2O7P (870.719)

SM 22:0;O2/24:1

C51H103N2O6P (870.7553)

SM 22:1;O2/24:0

C51H103N2O6P (870.7553)

SM 22:2;O2/23:0;O

C50H99N2O7P (870.719)

SM 45:2;O2;O

C50H99N2O7P (870.719)

SM 46:1;O2

C51H103N2O6P (870.7553)

β-sitosterol-3-o-β-d-glucoside-6'-o-eicosanate

C55H98O7 (870.7312)

{"Ingredient_id": "HBIN018291","Ingredient_name": "\u03b2-sitosterol-3-o-\u03b2-d-glucoside-6'-o-eicosanate","Alias": "NA","Ingredient_formula": "C55H98O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19972","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

n-[1-({4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl}oxy)-3,4-dihydroxy-17-methyloctadecan-2-yl]tricosanimidic acid

C50H98N2O9 (870.7272)

6-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl icosanoate

C55H98O7 (870.7312)